Topical tacrolimus for parastomal pyoderma gangrenosum: A report of two cases

Ostomy Wound Management

Volumn 56, Issue 9, 2010, Pages 56-59

  Altieri, Maria ^a   Vaziri, Khashayar ^a   Orkin, Bruce A ^b  

^a MSIV ^*  (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

colostomy; parastomal ulcer; pyoderma gangrenosum; tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; CASE REPORT; COLON; FEMALE; HUMAN; MIDDLE AGED; PYODERMA GANGRENOSUM;

COLON; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PYODERMA GANGRENOSUM; TACROLIMUS;

EID: 77957199543     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Brunsting L.A., Goeckerman W.H., O'Leary, PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol. 1930;22:655-680.
2. Callen J P. Pyoderma gangrenosum. Lancet. 1998;351:581-585.
3. Bennett M.L., Jackson J.L., Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from two institutions. Medicine. 2000;79:37-46.
4. Margoles J.S., Wenger J. Stomal ulceration associated with pyoderma gan-grenosum and chronic ulcerative colitis. Report of two cases. Gastroenterol. 1961;41:594-598.
5. McGarity W.C., Robertson D.B., McKeown P P, et al. Pyoderma gangrenosum at the parastomal site in patients with Crohn's disease. Arch Surg. 1984;119(10):1186-1188.
6. Yeo H., Abir F., Longo WE. Management of parastomal ulcers. World J Gastroenterol. 2006;12(20):3133-3137.
7. Hughes A P, Jackson JM, Callen J P. Clinical features and treatment of paras-tomal pyoderma gangrenosum. JAMA. 2000;284(12):1546-1548.
8. Powell R.J., Holbrook M.R., Stevens A. Pyoderma gangrenosum and its treatment. Lancet. 1997;350(9093):1720-1721.
9. Poritz, LS, Lebo MA, Bobb AD, et al. Management of parastomal pyoderma gangrenosum. J Am Coll Surg. 2008;206:311-315.
10. Daniels N.H., Callen J P. Mycophenolate mofetil is an effective treatment for parastomal pyoderma gangrenosum. Arch Dermatol. 2004;140:1427-1429.
11. Callen P.C., Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin N Am. 2007;33:787-802.
12. Price V., Willey A., Chen B. Topical tacrolimus in alopecia areata. JAAD. 2005;52(1):138-139.
13. Choi C.J., Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease. A case series of 18 patients. Arch Dermatol. 2001;137:1202-1206.
14. Grimes P.E., Soriano T., Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. JAAD. 2002;47(5):789-791.
15. Ruzicka T., Bieber T., Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. New Engl J Med. 1997;337(12):816-821.
16. Schuppe H.C., Homey B., Assmann T., et al. Topical tacrolimus for pyoderma gangrenosum. Lancet. 1998;351:832.
17. Reich K., Vente C., Neumann C. Treatment of pyoderma gangrenosum with topical tacrolimus. Br J Dermatol. 1998;139(4):755-757.
18. D'Inca R, Fagiuoli S, Sturniolo GC. Tacrolimus to treat pyoderma gangreno-sum resistant to cyclosporine. Ann Int Med. 1998;128(9):783-784.
19. Lyon C.C., Stapleton M., Smith AJ, et al. Topical tacrolimus in the management of parastomal pyoderma gangrenosum. J Dermatol Treat. 2001;12:13-17.
20. Baig M.K., Marquez H., Nogueras JJ, et al. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases. Colorect Dis. 2004;6:250-253.